文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

体外膜氧合与成人重症幸存者新发精神健康诊断的相关性

Association of Extracorporeal Membrane Oxygenation With New Mental Health Diagnoses in Adult Survivors of Critical Illness.
PubMed 文献 · JAMA · 2022-01-01
一句话结论成人ICU幸存者中,接受ECMO者出院后新发精神健康诊断风险轻度升高(HR 1.24,95%CI 1.01-1.52),物质滥用与故意自伤无显著差异。

该基于加拿大安大略省2010年4月1日至2020年3月31日的回顾性队列研究,纳入ICU存活出院成人4462例,其中642例接受ECMO,3820例未接受ECMO。主要终点为新发精神健康诊断复合终点,ECMO组发生率22.1/100人年(95%CI 19.5-25.1),非ECMO组14.5/100人年(95%CI 13.8-15.2),绝对率差7.6/100人年(95%CI 4.7-10.5);倾向评分加权后HR 1.24(95%CI 1.01-1.52)。物质滥用与故意自伤风险无显著差异,自杀死亡全队列少于5例。作者认为需进一步研究阐明潜在机制。

要点

  • 成人ICU存活出院者中,ECMO组新发精神健康诊断发生率为22.1/100人年(95%CI 19.5-25.1),非ECMO组为14.5/100人年(95%CI 13.8-15.2)。
  • 倾向评分加权后,ECMO与出院后新发精神健康诊断风险轻度升高相关(HR 1.24,95%CI 1.01-1.52)。
  • ECMO组与非ECMO组物质滥用风险无显著差异(HR 0.86,95%CI 0.48-1.53)。
  • ECMO组与非ECMO组故意自伤风险无显著差异(HR 0.68,95%CI 0.21-2.23)。
  • 全队列自杀死亡病例少于5例。

适用人群与场景

  • 2010年4月1日至2020年3月31日加拿大安大略省成人(年龄≥18岁)ICU患者,且存活至出院(N=4462);其中642例接受ECMO,3820例未接受ECMO。

研究设计与关键结果

  • 研究类型:基于人群的回顾性队列研究;地点:加拿大安大略省;时间:2010年4月1日至2020年3月31日;样本量N=4462。
  • ECMO组642例(平均年龄50.7岁;女性40.7%),中位随访730天;非ECMO匹配ICU幸存者3820例(平均年龄51.0岁;女性40.0%),中位随访1390天。
  • 主要终点新发精神健康诊断:ECMO组22.1/100人年(95%CI 19.5-25.1) vs 非ECMO组14.5/100人年(95%CI 13.8-15.2),绝对率差7.6/100人年(95%CI 4.7-10.5);倾向评分加权后HR 1.24(95%CI 1.01-1.52)。
  • 物质滥用:ECMO组1.6/100人年(95%CI 1.1-2.4) vs 非ECMO组1.4/100人年(95%CI 1.2-1.6),绝对率差0.2/100人年(95%CI -0.4-0.8),HR 0.86(95%CI 0.48-1.53),无显著差异。
  • 故意自伤:ECMO组0.4/100人年(95%CI 0.2-0.9) vs 非ECMO组0.3/100人年(95%CI 0.2-0.3),绝对率差0.1/100人年(95%CI -0.2-0.4),HR 0.68(95%CI 0.21-2.23),无显著差异。
  • 全队列自杀死亡少于5例。

证据类型、等级与局限

  • 证据类型:基于人群的回顾性队列研究;原文未报告证据等级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,成人重症幸存者接受ECMO与出院后新发精神健康诊断或社会问题诊断风险轻度升高相关;需进一步研究阐明潜在机制。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Extracorporeal membrane oxygenation (ECMO) is used as temporary cardiorespiratory support in critically ill patients, but little is known regarding long-term psychiatric sequelae among survivors after ECMO.

OBJECTIVE: To investigate the association between ECMO survivorship and postdischarge mental health diagnoses among adult survivors of critical illness.

DESIGN, SETTING, AND PARTICIPANTS: Population-based retrospective cohort study in Ontario, Canada, from April 1, 2010, through March 31, 2020. Adult patients (N=4462; age ≥18 years) admitted to the intensive care unit (ICU), and surviving to hospital discharge were included.

EXPOSURES: Receipt of ECMO.

MAIN OUTCOMES AND MEASURES: The primary outcome was a new mental health diagnosis (a composite of mood disorders, anxiety disorders, posttraumatic stress disorder; schizophrenia, other psychotic disorders; other mental health disorders; and social problems) following discharge. There were 8 secondary outcomes including incidence of substance misuse, deliberate self-harm, death by suicide, and individual components of the composite primary outcome. Patients were compared with ICU survivors not receiving ECMO using overlap propensity score-weighted cause-specific proportional hazard models.

RESULTS: Among 642 survivors who received ECMO (mean age, 50.7 years; 40.7% female), median length of follow-up was 730 days; among 3820 matched ICU survivors who did not receive ECMO (mean age, 51.0 years; 40.0% female), median length of follow-up was 1390 days. Incidence of new mental health conditions among survivors who received ECMO was 22.1 per 100-person years (95% confidence interval [CI] 19.5-25.1), and 14.5 per 100-person years (95% CI, 13.8-15.2) among non-ECMO ICU survivors (absolute rate difference of 7.6 per 100-person years [95% CI, 4.7-10.5]). Following propensity weighting, ECMO survivorship was significantly associated with an increased risk of new mental health diagnosis (hazard ratio [HR] 1.24 [95% CI, 1.01-1.52]). There were no significant differences between survivors who received ECMO vs ICU survivors who did not receive ECMO in substance misuse (1.6 [95% CI, 1.1 to 2.4] per 100 person-years vs 1.4 [95% CI, 1.2 to 1.6] per 100 person-years; absolute rate difference, 0.2 per 100 person-years [95% CI, -0.4 to 0.8]; HR, 0.86 [95% CI, 0.48 to 1.53]) or deliberate self-harm (0.4 [95% CI, 0.2 to 0.9] per 100 person-years vs 0.3 [95% CI, 0.2 to 0.3] per 100 person-years; absolute rate difference, 0.1 per 100 person-years [95% CI, -0.2 to 0.4]; HR, 0.68 [95% CI, 0.21 to 2.23]). There were fewer than 5 total cases of death by suicide in the entire cohort.

CONCLUSIONS AND RELEVANCE: Among adult survivors of critical illness, receipt of ECMO, compared with ICU hospitalization without ECMO, was significantly associated with a modestly increased risk of new mental health diagnosis or social problem diagnosis after discharge. Further research is necessary to elucidate the potential mechanisms underlying this relationship.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Fernando SM, Scott M, Talarico R, et al. Association of Extracorporeal Membrane Oxygenation With New Mental Health Diagnoses in Adult Survivors of Critical Illness. JAMA. 2022. PMID: 36286084. doi:10.1001/jama.2022.17714

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。